Chemotherapy of advanced breast cancer: outcome and prognostic factors
Authors:
Open Access
- 1 November 1993
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 68 (5) , 988-995
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The influence of adjuvant chemotherapy on outcome after relapse for patients with breast cancerEuropean Journal of Cancer, 1993
- Mitoxantrone in advanced breast cancer—a phase II study with special attention to cardiotoxicityEuropean Journal of Cancer and Clinical Oncology, 1984
- A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer A Cancer and Leukemia Group B studyAmerican Journal of Clinical Oncology, 1984
- Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1984
- Adriamycin alone or combined with vincristine in the treatment of advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast.1980
- PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER TREATED WITH COMBINATION CHEMOTHERAPY1979
- Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trialCancer, 1978
- Combined cytotoxic and progestogen therapy for advanced breast cancerCancer, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977